Ben Lamm

Sometimes it's knocking out that block.

And all these different technologies have different kind of off-target effects.

And we try to bundle them.

And that's what's called multiplex editing when we're editing multiple parts of the genome at the same time.

We've actually built an algorithm because we're creating so many cell lines and screening so much data that we then feed that back into this loop so that we can understand, you know, which types of edits make the highest efficiency for that type of effect without causing kind of this like disruption downstream in the genome and all that's using AI.

So I'll tell you, these projects would take, you know, decades if we didn't have AI.

And I think some of them probably wouldn't even be able to be done.

That's incredible.

Yeah, it's truly remarkable.

And what's interesting is now with quantum just around the corner, it's going to be really, really interesting probably what the next five years holds for us in terms of how we can engineer more and more species and even fill in gaps of species that we don't have full DNA of.

Well, I mean, just being able to look at and run to get to the point that we can actually run simulations of genome engineering, because we're not there yet from a compute perspective.

We're not there that from an AI or

um a data perspective but we're generating so much data that if we could actually run simulations in real time of all the possible variants and all the possible outcomes i think you'd at least give us some high degree of probability of like what that simulated outcome could be without us even having to do any of the wet lab experiment wow himself yeah

So, I mean, we're not there yet because the tech's not there yet.

But I think that, you know, in the next five to ten years, that's where we'll be.

There's a story that came out a couple weeks ago, and they weren't using quantum, but they actually did a mock.

They called it a mock trial, like a mock clinical trial, which I think is a weird term.

I think it kind of like almost belittles what they did, but they took all this data for cancer drugs.

And then they actually found out that these drugs that are already approved by the FDA and being treating different types of cancers actually can help with Alzheimer's and these other conditions.

Right.